Antimicrobial Agents and Chemotherapy, December 2004, p. 4931, Vol. 48, No. 12
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.12.4931.2004
| ERRATUM |
California Institute for Medical Research and Department of Medicine, Division of Infectious Diseases, Santa Clara Valley Medical Center, San Jose, and Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California
Volume 48, no. 10, p. 4063-4066, 2004. Page 4064, column 2: The last sentence should read "AmB and POS (POS was used at 5, 25, or 100 mg/kg) were equivalent in reducing CFU from either brain or kidneys."
Page 4065, column 1: The second sentence of the first full paragraph should read "CAS, the first of the echinocandins to be licensed, for use as salvage therapy in invasive aspergillosis, inhibits the synthesis of 1,3-ß-D-glucan, a component of the fungal cell wall (10, 36)."
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»